Cargando…

Clinical scales in autoimmune encephalitis—A retrospective monocentric cohort study

OBJECTIVE: Assessing severity of antibody‐mediated encephalitis (AE) or paraneoplastic encephalitis (PE) requires valid and reliable scores to guide treatment decisions and predict outcome both in clinical routine and studies. We aimed to validate the prognostic value of the clinical assessment scal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macher, Stefan, Bsteh, Gabriel, Höftberger, Romana, Berger, Thomas, Rommer, Paulus, Zrzavy, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578879/ https://www.ncbi.nlm.nih.gov/pubmed/37545101 http://dx.doi.org/10.1002/acn3.51865

Ejemplares similares

Longitudinal CSF Findings in Autoimmune Encephalitis—A Monocentric Cohort Study
por: Zrzavy, Tobias, et al.
Publicado: (2021)

Management of Autoimmune Encephalitis: An Observational Monocentric Study of 38 Patients
por: Macher, Stefan, et al.
Publicado: (2018)

Longitudinal measurement of cerebrospinal fluid neurofilament light in anti‐N‐methyl‐D‐aspartate receptor encephalitis
por: Macher, Stefan, et al.
Publicado: (2020)

Autoimmune Global Amnesia as Manifestation of AMPAR Encephalitis and Neuropathologic Findings
por: Ricken, Gerda, et al.
Publicado: (2021)

Immunosenescence in Neurological Diseases—Is There Enough Evidence?
por: Rommer, Paulus S, et al.
Publicado: (2022)

Ocular Motor Abnormalities in Anti-IgLON5 Disease
por: Macher, Stefan, et al.
Publicado: (2021)

Detection Methods for Autoantibodies in Suspected Autoimmune Encephalitis
por: Ricken, Gerda, et al.
Publicado: (2018)

Evaluation of Retinal Layer Thickness Parameters as Biomarkers in a Real-World Multiple Sclerosis Cohort
por: Schurz, Natascha, et al.
Publicado: (2021)

Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis
por: Monschein, Tobias, et al.
Publicado: (2020)

Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trial
por: Altmann, Patrick, et al.
Publicado: (2022)

Has the pandemic changed treatment strategy in multiple sclerosis?
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Immunology of COVID‐19 and disease‐modifying therapies: The good, the bad and the unknown
por: Zrzavy, Tobias, et al.
Publicado: (2020)

Predisposing Factors for Sexual Dysfunction in Multiple Sclerosis
por: Altmann, Patrick, et al.
Publicado: (2021)

Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple Sclerosis
por: Bsteh, Gabriel, et al.
Publicado: (2023)

Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple Sclerosis
por: Krajnc, Nik, et al.
Publicado: (2022)

The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study
por: Altmann, Patrick, et al.
Publicado: (2021)

Functional Recovery in Autoimmune Encephalitis: A Prospective Observational Study
por: Seifert-Held, Thomas, et al.
Publicado: (2021)

Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?
por: Höftberger, Romana, et al.
Publicado: (2015)

Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis
por: Bsteh, Gabriel, et al.
Publicado: (2021)

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
por: Monschein, Tobias, et al.
Publicado: (2023)

Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
por: Monschein, Tobias, et al.
Publicado: (2023)

Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Performance of the clinical assessment scale for autoimmune encephalitis in a pediatric autoimmune encephalitis cohort
por: Zhou, Hao, et al.
Publicado: (2022)

Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
por: Zrzavy, Tobias, et al.
Publicado: (2021)

Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Remote visits for people with multiple sclerosis during the COVID-19 pandemic in Austria: The TELE MS randomized controlled trial
por: Altmann, Patrick, et al.
Publicado: (2022)

Cerebrospinal Fluid Findings in 541 Patients With Clinically Isolated Syndrome and Multiple Sclerosis: A Monocentric Study
por: Berek, Klaus, et al.
Publicado: (2021)

Exome-Sequence Analyses of Four Multi-Incident Multiple Sclerosis Families
por: Zrzavy, Tobias, et al.
Publicado: (2020)

Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study
por: Bsteh, Gabriel, et al.
Publicado: (2021)

Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen für Patienten – Teil 1: Empfehlungen
por: Monschein, Tobias, et al.
Publicado: (2021)

Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen für Patienten – Teil 2: Impfstofftechnologien
por: Monschein, Tobias, et al.
Publicado: (2021)

Effects of normobaric hypoxic endurance training on fatigue in patients with multiple sclerosis: a randomized prospective pilot study
por: Zrzavy, Tobias, et al.
Publicado: (2021)

Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center study
por: Blechinger, Stephan, et al.
Publicado: (2021)

Neuroimmunology: An Expanding Frontier in Autoimmunity
por: Höftberger, Romana
Publicado: (2015)

Multiple sclerosis and COVID‐19: How many are at risk?
por: Bsteh, Gabriel, et al.
Publicado: (2020)

Vaccination and multiple sclerosis in the era of the COVID-19 pandemic
por: Monschein, Tobias, et al.
Publicado: (2021)

Association of Cerebrospinal Fluid Parameters and Neurofilament Light Chain With Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
por: Krajnc, Nik, et al.
Publicado: (2022)

Acute and non-resolving inflammation associate with oxidative injury after human spinal cord injury
por: Zrzavy, Tobias, et al.
Publicado: (2020)

Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies
por: Wegener-Panzer, Andreas, et al.
Publicado: (2020)

Humoral immune response to SARS-CoV-2 third vaccination in patients with multiple sclerosis and healthy controls: A prospective multicenter study
por: Krajnc, Nik, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dom2g1k6i6er1rc60p2b3vs3bp